ArticleResearch square2024

Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization.

Maitreyee K Jathal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.